International Journal of Molecular and Cellular Medicine (IJMCM)
Cellular and Molecular Biology Research Center, Babol University of Medical Sciences
Thu, Nov 21, 2024
[Archive]
Volume 13, Issue 3 (Int J Mol Cell Med 2024)
Int J Mol Cell Med 2024, 13(3): 325-336 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azar Bahadori R, Shabani D, Arjmandrad E, Kazerani M, Rohani M, Ramazani Karim Z, et al . Circulating miRNA-106b-5p As a Potential Biomarker for Coronary Artery Disease. Int J Mol Cell Med 2024; 13 (3) :325-336
URL: http://ijmcmed.org/article-1-2256-en.html
URL: http://ijmcmed.org/article-1-2256-en.html
Rosita Azar Bahadori1 
, Dina Shabani2 , Elham Arjmandrad3 , Mahsa Kazerani4 , Mina Rohani5 , Zohreh Ramazani Karim6 , Masoud Ali-Kheyl7 , Reza Nosratabadi8 , Hossein Pourghadamyari 9, Mohammad Ali Zaemi10
, Dina Shabani2 , Elham Arjmandrad3 , Mahsa Kazerani4 , Mina Rohani5 , Zohreh Ramazani Karim6 , Masoud Ali-Kheyl7 , Reza Nosratabadi8 , Hossein Pourghadamyari 9, Mohammad Ali Zaemi10
1- Department of Molecular Genetics, Parand Branch, Islamic Azad University, Tehran, Iran.
2- Cellular and Molecular Biology, Department of Biology. Science Faculty, Science and Art University, Yazd, Iran.
3- Department of Molecular and Cellular Sciences, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
4- Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
5- Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
6- Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
7- Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
8- Department of Medical Immunology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
9- Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran. ,ghadamyarih91@gmail.com
10- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2- Cellular and Molecular Biology, Department of Biology. Science Faculty, Science and Art University, Yazd, Iran.
3- Department of Molecular and Cellular Sciences, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
4- Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
5- Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
6- Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
7- Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
8- Department of Medical Immunology, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
9- Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran. ,
10- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract: (361 Views)
Coronary artery diseases (CAD) represent a significant global health concern and are recognized as a primary contributor to mortality on a worldwide scale. Early diagnosis of CAD is one of promising goal to manage this disorder. Recent investigations have highlighted the pivotal involvement of microRNAs (miRNAs) in diverse health conditions, notably CAD. The principal objective of this investigation was to identify appropriate miRNAs that could be employed for the early detection of CAD. In the present study, we analyzed dataset of CAD (GSE113079) and 100 differentially expressed mRNAs (DEmRNAs) were detected. The miRNAs that have a significant interaction with DEmRNAs were chosen. By computational prediction method, 5 miRNAs (miR-106b-5p, miR-20a-3p, miR-17-3p, miR-146a-5p, and miR-155-3p) were selected. Finally, we assessed the anticipated expression levels of microRNAs in CAD patients and healthy control groups. Our findings revealed a statistically significant elevation solely in the expression level of miR-106b-5p within the CAD group when compared to the control group (p>0.001). Our study demonstrated an elevation in the expression of miR-106b-5p in individuals diagnosed with CAD. This microRNA may be used as a diagnostic biomarker in patients with CAD. However, further investigations are needed to confirm these results.
Type of Study: Original Article |
Subject:
Biomarkers (diagnosis & treatment)
Received: 2023/12/6 | Accepted: 2024/07/7 | Published: 2024/08/28
Received: 2023/12/6 | Accepted: 2024/07/7 | Published: 2024/08/28
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
